Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cleveland Clinic
MedTech
FDA approves next-gen PSA test from Cleveland Diagnostics
The IsoPSA blood test looks for specific variants of the PSA protein that can be linked to higher risks of malignant disease.
Conor Hale
Dec 3, 2025 10:05am
Tumor microbes in young colorectal patients differ from old ones
Feb 6, 2024 5:15am
Next-gen PSA test maker Cleveland Dx rocks to $75M fundraising
Jan 29, 2024 11:07am
Cleveland Clinic, Canon collab on imaging research center
Dec 1, 2023 10:12am
Theken acquires 3D-printed airway stent maker VisionAir
Aug 25, 2023 10:29am
How COVID-19 and cancer could be treated with the same drug
Nov 17, 2022 3:20pm
